APO Research
Talk to an analyst

APO RESEARCH · REPORT

Toxicity Estimation Software Tool (TEST)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Toxicity Estimation Software Tool (TEST) Market Outlook and Growth Opportunities 2026

12 August 2026195 pages

Choose your research edition.

Industry ResearchToxicity Estimation Software Tool (TEST) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Toxicity Estimation Software Tool (TEST) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Toxicity Estimation Software Tool (TEST) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Toxicity Estimation Software Tool (TEST) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Toxicity Estimation Software Tool (TEST) Market Analysis and Forecast 2026-2032175 pages · $4,950 USD

Market perspective

The global Toxicity Estimation Software Tool (TEST) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Toxicity Estimation Software Tool (TEST) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Toxicity Estimation Software Tool (TEST) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Toxicity Estimation Software Tool (TEST) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Toxicity Estimation Software Tool (TEST) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Toxicity Estimation Software Tool (TEST) market include Inotiv, Simulations Plus Inc, Schrodinger, Aclaris, Evogene, Deciphex (Patholytix), Exscientia, Instem (Leadscope) and Lhasa Limited, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Toxicity Estimation Software Tool (TEST) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Toxicity Estimation Software Tool (TEST) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Toxicity Estimation Software Tool (TEST) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Toxicity Estimation Software Tool (TEST) market.

Toxicity Estimation Software Tool (TEST) Segment by Company

Inotiv

Simulations Plus Inc

Schrodinger

Aclaris

Evogene

Deciphex (Patholytix)

Exscientia

Instem (Leadscope)

Lhasa Limited

MultiCASE

Toxicity Estimation Software Tool (TEST) Segment by Type

On-Premise

Cloud-Based

Toxicity Estimation Software Tool (TEST) Segment by Application

Academia

Enterprise

Toxicity Estimation Software Tool (TEST) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Toxicity Estimation Software Tool (TEST) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Toxicity Estimation Software Tool (TEST) key companies, revenue, market share, and recent developments.

3. To split the Toxicity Estimation Software Tool (TEST) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Toxicity Estimation Software Tool (TEST) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Toxicity Estimation Software Tool (TEST) significant trends, drivers, influence factors in global and regions.

6. To analyze Toxicity Estimation Software Tool (TEST) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Toxicity Estimation Software Tool (TEST) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Toxicity Estimation Software Tool (TEST) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Toxicity Estimation Software Tool (TEST).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Toxicity Estimation Software Tool (TEST) industry.

Chapter 3: Detailed analysis of Toxicity Estimation Software Tool (TEST) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Toxicity Estimation Software Tool (TEST) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Toxicity Estimation Software Tool (TEST) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Toxicity Estimation Software Tool (TEST) Industry Trends Table 2. Toxicity Estimation Software Tool (TEST) Industry Drivers Table 3. Toxicity Estimation Software Tool (TEST) Industry Opportunities and Challenges Table 4. Toxicity Estimation Software Tool (TEST) Industry Restraints Table 5. Global Toxicity Estimation Software Tool (TEST) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Toxicity Estimation Software Tool (TEST) Revenue Share by Company (2021-2026) Table 7. Global Toxicity Estimation Software Tool (TEST) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Toxicity Estimation Software Tool (TEST) Key Company Manufacturing Base & Headquarters Table 9. Global Toxicity Estimation Software Tool (TEST) Company, Product Type & Application Table 10. Global Toxicity Estimation Software Tool (TEST) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Toxicity Estimation Software Tool (TEST) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-Premise Table 15. Significant Companies of Cloud-Based Table 16. Global Toxicity Estimation Software Tool (TEST) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Toxicity Estimation Software Tool (TEST) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Toxicity Estimation Software Tool (TEST) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Toxicity Estimation Software Tool (TEST) Sales Value Share by Type (2021-2026) Table 20. Global Toxicity Estimation Software Tool (TEST) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Academia Table 22. Significant Companies of Enterprise Table 23. Global Toxicity Estimation Software Tool (TEST) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Toxicity Estimation Software Tool (TEST) Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Toxicity Estimation Software Tool (TEST) Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Toxicity Estimation Software Tool (TEST) Sales Value Share by Application (2021-2026) Table 27. Global Toxicity Estimation Software Tool (TEST) Sales Value Share by Application (2027-2032) Table 28. Global Toxicity Estimation Software Tool (TEST) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Toxicity Estimation Software Tool (TEST) Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Toxicity Estimation Software Tool (TEST) Sales Value Share by Region (2021-2026) Table 31. Global Toxicity Estimation Software Tool (TEST) Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Toxicity Estimation Software Tool (TEST) Sales Value Share by Region (2027-2032) Table 33. Global Toxicity Estimation Software Tool (TEST) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Toxicity Estimation Software Tool (TEST) Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Toxicity Estimation Software Tool (TEST) Sales Value Market Share by Country (2021-2026) Table 36. Global Toxicity Estimation Software Tool (TEST) Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Toxicity Estimation Software Tool (TEST) Sales Value Market Share by Country (2027-2032) Table 38. Inotiv Company Information Table 39. Inotiv Business Overview Table 40. Inotiv Toxicity Estimation Software Tool (TEST) Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Inotiv Toxicity Estimation Software Tool (TEST) Product Portfolio Table 42. Inotiv Recent Development Table 43. Simulations Plus Inc Company Information Table 44. Simulations Plus Inc Business Overview Table 45. Simulations Plus Inc Toxicity Estimation Software Tool (TEST) Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Simulations Plus Inc Toxicity Estimation Software Tool (TEST) Product Portfolio Table 47. Simulations Plus Inc Recent Development Table 48. Schrodinger Company Information Table 49. Schrodinger Business Overview Table 50. Schrodinger Toxicity Estimation Software Tool (TEST) Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Schrodinger Toxicity Estimation Software Tool (TEST) Product Portfolio Table 52. Schrodinger Recent Development Table 53. Aclaris Company Information Table 54. Aclaris Business Overview Table 55. Aclaris Toxicity Estimation Software Tool (TEST) Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Aclaris Toxicity Estimation Software Tool (TEST) Product Portfolio Table 57. Aclaris Recent Development Table 58. Evogene Company Information Table 59. Evogene Business Overview Table 60. Evogene Toxicity Estimation Software Tool (TEST) Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Evogene Toxicity Estimation Software Tool (TEST) Product Portfolio Table 62. Evogene Recent Development Table 63. Deciphex (Patholytix) Company Information Table 64. Deciphex (Patholytix) Business Overview Table 65. Deciphex (Patholytix) Toxicity Estimation Software Tool (TEST) Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Deciphex (Patholytix) Toxicity Estimation Software Tool (TEST) Product Portfolio Table 67. Deciphex (Patholytix) Recent Development Table 68. Exscientia Company Information Table 69. Exscientia Business Overview Table 70. Exscientia Toxicity Estimation Software Tool (TEST) Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Exscientia Toxicity Estimation Software Tool (TEST) Product Portfolio Table 72. Exscientia Recent Development Table 73. Instem (Leadscope) Company Information Table 74. Instem (Leadscope) Business Overview Table 75. Instem (Leadscope) Toxicity Estimation Software Tool (TEST) Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Instem (Leadscope) Toxicity Estimation Software Tool (TEST) Product Portfolio Table 77. Instem (Leadscope) Recent Development Table 78. Lhasa Limited Company Information Table 79. Lhasa Limited Business Overview Table 80. Lhasa Limited Toxicity Estimation Software Tool (TEST) Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Lhasa Limited Toxicity Estimation Software Tool (TEST) Product Portfolio Table 82. Lhasa Limited Recent Development Table 83. MultiCASE Company Information Table 84. MultiCASE Business Overview Table 85. MultiCASE Toxicity Estimation Software Tool (TEST) Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. MultiCASE Toxicity Estimation Software Tool (TEST) Product Portfolio Table 87. MultiCASE Recent Development Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Toxicity Estimation Software Tool (TEST) Product Image Figure 2. Global Toxicity Estimation Software Tool (TEST) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Toxicity Estimation Software Tool (TEST) Market Size (2021-2032) & (US$ Million) Figure 4. Global Toxicity Estimation Software Tool (TEST) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-Premise Image Figure 8. Cloud-Based Image Figure 9. Global Toxicity Estimation Software Tool (TEST) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Toxicity Estimation Software Tool (TEST) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Toxicity Estimation Software Tool (TEST) Sales Value Share by Type (2021-2032) Figure 12. Academia Image Figure 13. Enterprise Image Figure 14. Global Toxicity Estimation Software Tool (TEST) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Toxicity Estimation Software Tool (TEST) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Toxicity Estimation Software Tool (TEST) Sales Value Share by Application (2021-2032) Figure 17. Global Toxicity Estimation Software Tool (TEST) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Toxicity Estimation Software Tool (TEST) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Toxicity Estimation Software Tool (TEST) Sales Value (2021-2032) & (US$ Million) Figure 20. North America Toxicity Estimation Software Tool (TEST) Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Toxicity Estimation Software Tool (TEST) Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Toxicity Estimation Software Tool (TEST) Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Toxicity Estimation Software Tool (TEST) Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Toxicity Estimation Software Tool (TEST) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Toxicity Estimation Software Tool (TEST) Sales Value (2021-2032) & (US$ Million) Figure 26. South America Toxicity Estimation Software Tool (TEST) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Toxicity Estimation Software Tool (TEST) Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Toxicity Estimation Software Tool (TEST) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • On-Premise
  • Cloud-Based
Applications
  • Academia
  • Enterprise
Companies covered
  • Inotiv
  • Simulations Plus Inc
  • Schrodinger
  • Aclaris
  • Evogene
  • Deciphex (Patholytix)
  • Exscientia
  • Instem (Leadscope)
  • Lhasa Limited
  • MultiCASE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Toxicity Estimation Software Tool (TEST) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Toxicity Estimation Software Tool (TEST) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Toxicity Estimation Software Tool (TEST) Market Dynamics
  1. 2.1 Toxicity Estimation Software Tool (TEST) Industry Trends
  2. 2.2 Toxicity Estimation Software Tool (TEST) Industry Drivers
  3. 2.3 Toxicity Estimation Software Tool (TEST) Industry Opportunities and Challenges
  4. 2.4 Toxicity Estimation Software Tool (TEST) Industry Restraints
3 Toxicity Estimation Software Tool (TEST) Market by Company
  1. 3.1 Global Toxicity Estimation Software Tool (TEST) Company Revenue Ranking in 2025
  2. 3.2 Global Toxicity Estimation Software Tool (TEST) Revenue by Company (2021-2026)
  3. 3.3 Global Toxicity Estimation Software Tool (TEST) Company Ranking (2024-2026)
  4. 3.4 Global Toxicity Estimation Software Tool (TEST) Company Manufacturing Base and Headquarters
  5. 3.5 Global Toxicity Estimation Software Tool (TEST) Company Product Type and Application
  6. 3.6 Global Toxicity Estimation Software Tool (TEST) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Toxicity Estimation Software Tool (TEST) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Toxicity Estimation Software Tool (TEST) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Toxicity Estimation Software Tool (TEST) Market by Type
  1. 4.1 Toxicity Estimation Software Tool (TEST) Type Introduction
  2. 4.1.1 On-Premise
  3. 4.1.2 Cloud-Based
  4. 4.2 Global Toxicity Estimation Software Tool (TEST) Sales Value by Type
  5. 4.2.1 Global Toxicity Estimation Software Tool (TEST) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Toxicity Estimation Software Tool (TEST) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Toxicity Estimation Software Tool (TEST) Sales Value Share by Type (2021-2032)
5 Toxicity Estimation Software Tool (TEST) Market by Application
  1. 5.1 Toxicity Estimation Software Tool (TEST) Application Introduction
  2. 5.1.1 Academia
  3. 5.1.2 Enterprise
  4. 5.2 Global Toxicity Estimation Software Tool (TEST) Sales Value by Application
  5. 5.2.1 Global Toxicity Estimation Software Tool (TEST) Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Toxicity Estimation Software Tool (TEST) Sales Value by Application (2021-2032)
  7. 5.2.3 Global Toxicity Estimation Software Tool (TEST) Sales Value Share by Application (2021-2032)
6 Toxicity Estimation Software Tool (TEST) Regional Value Analysis
  1. 6.1 Global Toxicity Estimation Software Tool (TEST) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Toxicity Estimation Software Tool (TEST) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Toxicity Estimation Software Tool (TEST) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Toxicity Estimation Software Tool (TEST) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Toxicity Estimation Software Tool (TEST) Sales Value (2021-2032)
  7. 6.3.2 North America Toxicity Estimation Software Tool (TEST) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Toxicity Estimation Software Tool (TEST) Sales Value (2021-2032)
  10. 6.4.2 Europe Toxicity Estimation Software Tool (TEST) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Toxicity Estimation Software Tool (TEST) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Toxicity Estimation Software Tool (TEST) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Toxicity Estimation Software Tool (TEST) Sales Value (2021-2032)
  16. 6.6.2 South America Toxicity Estimation Software Tool (TEST) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Toxicity Estimation Software Tool (TEST) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Toxicity Estimation Software Tool (TEST) Sales Value Share by Country, 2025 VS 2032
7 Toxicity Estimation Software Tool (TEST) Country-level Value Analysis
  1. 7.1 Global Toxicity Estimation Software Tool (TEST) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Toxicity Estimation Software Tool (TEST) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Toxicity Estimation Software Tool (TEST) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Toxicity Estimation Software Tool (TEST) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Toxicity Estimation Software Tool (TEST) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Toxicity Estimation Software Tool (TEST) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Toxicity Estimation Software Tool (TEST) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Inotiv
  2. 8.1.1 Inotiv Company Information
  3. 8.1.2 Inotiv Business Overview
  4. 8.1.3 Inotiv Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Inotiv Toxicity Estimation Software Tool (TEST) Product Portfolio
  6. 8.1.5 Inotiv Recent Developments
  7. 8.2 Simulations Plus Inc
  8. 8.2.1 Simulations Plus Inc Company Information
  9. 8.2.2 Simulations Plus Inc Business Overview
  10. 8.2.3 Simulations Plus Inc Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Simulations Plus Inc Toxicity Estimation Software Tool (TEST) Product Portfolio
  12. 8.2.5 Simulations Plus Inc Recent Developments
  13. 8.3 Schrodinger
  14. 8.3.1 Schrodinger Company Information
  15. 8.3.2 Schrodinger Business Overview
  16. 8.3.3 Schrodinger Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Schrodinger Toxicity Estimation Software Tool (TEST) Product Portfolio
  18. 8.3.5 Schrodinger Recent Developments
  19. 8.4 Aclaris
  20. 8.4.1 Aclaris Company Information
  21. 8.4.2 Aclaris Business Overview
  22. 8.4.3 Aclaris Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Aclaris Toxicity Estimation Software Tool (TEST) Product Portfolio
  24. 8.4.5 Aclaris Recent Developments
  25. 8.5 Evogene
  26. 8.5.1 Evogene Company Information
  27. 8.5.2 Evogene Business Overview
  28. 8.5.3 Evogene Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Evogene Toxicity Estimation Software Tool (TEST) Product Portfolio
  30. 8.5.5 Evogene Recent Developments
  31. 8.6 Deciphex (Patholytix)
  32. 8.6.1 Deciphex (Patholytix) Company Information
  33. 8.6.2 Deciphex (Patholytix) Business Overview
  34. 8.6.3 Deciphex (Patholytix) Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Deciphex (Patholytix) Toxicity Estimation Software Tool (TEST) Product Portfolio
  36. 8.6.5 Deciphex (Patholytix) Recent Developments
  37. 8.7 Exscientia
  38. 8.7.1 Exscientia Company Information
  39. 8.7.2 Exscientia Business Overview
  40. 8.7.3 Exscientia Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Exscientia Toxicity Estimation Software Tool (TEST) Product Portfolio
  42. 8.7.5 Exscientia Recent Developments
  43. 8.8 Instem (Leadscope)
  44. 8.8.1 Instem (Leadscope) Company Information
  45. 8.8.2 Instem (Leadscope) Business Overview
  46. 8.8.3 Instem (Leadscope) Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Instem (Leadscope) Toxicity Estimation Software Tool (TEST) Product Portfolio
  48. 8.8.5 Instem (Leadscope) Recent Developments
  49. 8.9 Lhasa Limited
  50. 8.9.1 Lhasa Limited Company Information
  51. 8.9.2 Lhasa Limited Business Overview
  52. 8.9.3 Lhasa Limited Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lhasa Limited Toxicity Estimation Software Tool (TEST) Product Portfolio
  54. 8.9.5 Lhasa Limited Recent Developments
  55. 8.10 MultiCASE
  56. 8.10.1 MultiCASE Company Information
  57. 8.10.2 MultiCASE Business Overview
  58. 8.10.3 MultiCASE Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MultiCASE Toxicity Estimation Software Tool (TEST) Product Portfolio
  60. 8.10.5 MultiCASE Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst